Summary
After a brief discussion of the theory of disturbed neuronal calcium metabolism an overview is given on the results of clinical studies with nimodipine in the treatment of vascular and Alzheimer’s dementia.
Calcium seems to be the essential if not the only intracellular signal transmitter, on which all the signals transduced by the different transmitter systems converge, modulating the intracellular calcium concentration. Secondly disturbance to the intracellular calcium homeostasis is the common mechanism by which noxious interventions, like for instance hypoxia, deteriorate cell function, and finally even lead to cell death. There have been many experimental data showing that the ability of cells to sustaine calcium homeostasis might be impaired by the aging process itself. The hypothesis has been postulated, that this impairment might also be of central importance for brain aging, associated cognitive decline and development of dementia. In that sense the age dependent increasing incapacitation of the intraneuronal calcium regulating processes could be viewed as risk factors causing the increasing susceptibility of brain cells against any noxious agents including etiology of dementia in general and Alzheimer’s dementia in particular. Khachaturian (1989) has argued that a longlasting continuous and rather small impairment of calcium homeostasis may have the same effect as an acute and massive calcium overloading of neuronal cells as for example induced by acute ischemic states.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Etcheberrigaray R, Ito E, Oka K, et al (1994) Soluble β-amyloid induction of Alzheimer’s phenotype for human fibroblast K+ channels. Science 264: 276–279
Fischhof P, Wagner G, Littschauer, et al (1989) Therapeutic results with nimodipine in primary degenerative dementia and multi-infarct dementia. In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York Tokyo, pp 350–359
Grobe-Einsler R (1993) Clinical aspects of nimodipine. Clin Neuropharmacol 16 [Suppl 1]: 39–45
Hartmann H, Eckert A, Velbinger K, et al (1996) Down-regulation of free intracellular calcium in dissociated brain cells of aged mice and rats. Life Sci 59: 435–449
Kanowski S, Fischhof P, Hiersemenzel R, et al (1988) Wirksamkeitsnachweis von Nootropika am Beispiel von Nimodipin — ein Beitrag zur Entwicklung geeigneter klinischer Prüfmodelle. Z Gerontopsychol psychiatr 1: 35–44
Kanowski S, Fischhof P, Hiersemenzel R, et al (1989) Therapeutic efficacy of nootropic drugs — A discussion of clinical phase III studies with nimodipine as a model. In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York Tokyo, pp 339–349
Khachaturian ZS (1989) The role of calcium regulation in brain aging: reexamination of a hypothesis. Aging 1: 17–34
Morich FJ, Bieber F, Lewis JM, et al (1996) Nimodipine in the treatment of probable Alzheimer’s disease. Results of two multicenter trials. Clin Drug Invest 11: 185–195
Müller WE, Eckert A, Hartmann H, et al (1996) Zur Kalziumhypothese der Hirnalterung. Nervenarzt 67: 15–24
Schmage N, Dycka J (1991) Auswertung von verschiedenen psychometrischen Verfahren aus klinischen Studien mit Nimodipin. In: Möller H-J (Hrsg) Hirnleistungsstörungen im Alter. Springer, Berlin Heidelberg New York Tokyo, pp 97–104
Schmage N, Bergener M (1992) Global rating, symptoms, behaviour and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes. Int Psychogeratr 4: 89–99
Zirm B, Steinwachs KC, Pracher G, et al (1994) Effects of nimodipine and piracetam on speed of information processing (ZVT: G) and clinical dementia symptoms — results of an unicenter randomized clinical trial. Z Gerontopsychol psychiatr 7: 157–168
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag/Wien
About this paper
Cite this paper
Kanowski, S. (1998). Aging, dementia and calcium metabolism. In: Gertz, HJ., Arendt, T. (eds) Alzheimer’s Disease — From Basic Research to Clinical Applications. Journal of Neural Transmission. Supplementa, vol 54. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7508-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7508-8_19
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83112-0
Online ISBN: 978-3-7091-7508-8
eBook Packages: Springer Book Archive